Abattis Bioceuticals Corp. (ATTBF)

[guay]

Important NEWS - Please read it ...
Abattis' Phytalab Receives Cannabis Lab Certification In Washington
Vancouver, BC – September 8th, 2014 - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. ("Phytalab.com"), its 51% controlled US subsidiary, has received provisional certification from the Washington State Liquor Control Board. This milestone enables the lab to legally offer service to the new legal Cannabis industry.

Link: http://www.abattis.com/s/news.asp?ReportID=673154

Phytalab is PhytaLAB is the original Washington Cannabis testing facility setting the standard for Good Laboratory Practice in the Cannabis industry. We come to this industry with extensive herbal product experience. We offer a range of services for growers, producer/processors and retail facilities and provide data on which to base informed business decisions. Our background in Botanical Medicine puts us first when you are looking for help in product development for specific plant chemotypes and standardization for reproducibility and efficacy. PhytaLAB offers consulting services to both business and regulatory entities. We can help with questions around methods, safety, packaging and labeling, and more. Please contact us for our unrivaled expertise.
www.Phytalab.com